Brainstorm Cell Therapeutics (BCLI) Earnings Date, Estimates & Call Transcripts $1.06 -0.02 (-1.85%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$1.06 +0.00 (+0.47%) As of 05/28/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Brainstorm Cell Therapeutics Earnings Summary Brainstorm Cell Therapeutics issued Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.45, which missed the consensus estimate of -$0.38 by $0.07. With a trailing EPS of -$3.36, Brainstorm Cell Therapeutics' earnings are expected to grow next year, from ($3.01) to ($1.60) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 15) -$0.38 Actual EPS (May. 15) -$0.45 Missed By -$0.07 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)BCLI Upcoming EarningsBrainstorm Cell Therapeutics' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Brainstorm Cell Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Brainstorm Cell Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBCLI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Brainstorm Cell Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.41-$0.41-$0.41Q3 20251-$0.35-$0.35-$0.35Q4 20251-$0.34-$0.34-$0.34 Brainstorm Cell Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/15/2025Q1 2025-$0.38-$0.45 -$0.07-$0.45--8/14/2024Q2 2024-$0.60-$0.60--$0.04--5/14/2024Q1 2024-$1.05-$0.75+$0.30-$0.05--4/1/2024Q4 2023-$2.25-$1.65+$0.60-$0.11--11/14/2023Q3 2023-$2.10-$2.10--$0.25--8/14/2023Q2 2023-$2.25-$4.05 -$1.80-$0.27-- Brainstorm Cell Therapeutics Earnings - Frequently Asked Questions When is Brainstorm Cell Therapeutics's earnings date? Brainstorm Cell Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on BCLI's earnings history. Did Brainstorm Cell Therapeutics beat their earnings estimates last quarter? In the previous quarter, Brainstorm Cell Therapeutics (NASDAQ:BCLI) missed the analysts' consensus estimate of ($0.38) by $0.07 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. BCLI's actual earnings. How can I listen to Brainstorm Cell Therapeutics's earnings conference call? The conference call for Brainstorm Cell Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Brainstorm Cell Therapeutics's conference call transcript? The conference call transcript for Brainstorm Cell Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Brainstorm Cell Therapeutics generate each year? Brainstorm Cell Therapeutics (NASDAQ:BCLI) has a recorded net income of -$17.19 million. BCLI has generated -$3.36 earnings per share over the last four quarters. What is Brainstorm Cell Therapeutics's EPS forecast for next year? Brainstorm Cell Therapeutics's earnings are expected to grow from ($3.01) per share to ($1.60) per share in the next year. More Earnings Resources from MarketBeat Related Companies FibroBiologics Earnings OS Therapies Earnings Barinthus Biotherapeutics Earnings Quantum Biopharma Earnings LAVA Therapeutics Earnings Coeptis Therapeutics Earnings Scilex Earnings SCYNEXIS Earnings Dyadic International Earnings FibroGen Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again? This page (NASDAQ:BCLI) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
